Table: Delta-Fly Pharma -2019/20 parent results

Delta-Fly Pharma

14/05/2020 08:00

May 14 (Reuters)- 
          Delta-Fly Pharma, Inc. 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended       Year ended        Year to         NEXT   
               Mar 31, 2020     Mar 31, 2019     Mar 31, 2021      YEAR     
                  LATEST          YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS          FORECAST     H1 FORECAST 
  Sales          100 mln                           300 mln                  
                                (-100.0 pct)     (+200.0 pct)               
  Operating     loss 1.55       loss 592 mln     loss 850 mln               
  Recurring     loss 1.55       loss 671 mln     loss 850 mln               
  Net           loss 1.56       loss 673 mln     loss 850 mln               
  EPS        loss 348.32 yen  loss 170.16 yen  loss 188.70 yen              
  Ann Div          NIL              NIL              NIL                    
  -Q2 Div          NIL              NIL              NIL                    
  -Q4 Div          NIL              NIL              NIL                    
  
  NOTE - Delta-Fly Pharma, Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4598.T